PCI Ventures (PCIV) is a division of PCI specifically focused on creating early-stage businesses founded on Penn technology.
PCIV prides itself on promoting entrepreneurial activities and new company formation around Penn’s leading research and innovations. PCIV actively seeks entrepreneurs to lead its companies and investors to provide funding for a portfolio of new ventures in development. PCIV also provides a suite of products and services to support its portfolio as spinouts make their way towards commercial success.
How PCIV Helps Penn Spinouts
Since 2010, PCIV has worked with over 200 faculty and staff members to form and launch new companies based on selected inventions and innovative technologies.
While there are many paths to commercialization of a new technology, the PCIV team works with Penn inventors to develop a commercial strategy that utilizes company creation as a means to increase the value of the technology while giving it exposure in the marketplace. PCIV will assist the business team through the entire commercialization process with an array of services that includes matching a strong entrepreneur to each company, providing a network of partners to help with any number of startup needs, and assisting with fundraising.
By connecting local entrepreneurs, investors and partners with Penn inventors, PCIV adds a powerful platform for a larger entrepreneurial ecosystem in greater Philadelphia and beyond.
PCI Ventures Services
UPstart
UPstart offers a wide array of services to assist entrepreneurial faculty members with the company formation and development process. UPstart smooths the path to future success by working closely with faculty members to create a commercial opportunity for their technology through a new venture.
UPadvisors
UPadvisors provides support to companies that operate independently and want to leverage the resources of the PCI Ventures team, services, programs, and network to help navigate the challenges of an early-stage startup. PCI Ventures provides a Company Formation Handbook and advises UPadvisors companies during Weekly Office Hours.
Venture WarmUP
Venture WarmUP is designed to assist faculty prior to starting a company as they explore different options for technology development and commercialization. Program participants may choose to work with PCI to pursue licensing or R&D alliance opportunities, start a company through PCI Ventures, start a company on their own (or with an outside partner), or simply continue with additional research.
Read about successful companies in the PCIV portfolio here.
Ready to get started? Contact PCIVentures@lists.upenn.edu
PCI Ventures Weekly Office Hours
PCI Ventures hosts virtual office hours every Wednesday from 9:00 to 12:00. Each week, a member of the PCI Ventures team will be available to answer business questions on topics ranging from company formation and legal agreements to benefits and insurance.
Anyone is welcome to take advantage of the office hours, click here to sign up for a session today!
Ace Genomics, Inc.
Ace Genomics, Inc.
Developing enzymes to assess epigenetic modifications to allow for advanced research tools and diagnostics.
Penn Founder: Rahul Kohli, MD, PhD (Penn Medicine)
Participation: PCI Ventures (WarmUP)
Enteropass
Enteropass
Developing novel enteric bypass solutions to change the paradigm of enterocutaneous fistula management
Penn Founder: Daniel Holena, MD (Penn Medicine)
PCI Ventures (UPadvisors)
Prolifagen
Prolifagen
Developing microRNA therapies to treat myocardial infarction, prevent remodeling, and regenerate tissue
Penn Founder: Edward Morrisey, PhD (Penn Medicine)
PCI Ventures (UPadvisor)
Stage One Immunotherapeutics
Stage One Immunotherapeutics
Developing small molecules that target retinoic acid signaling pathways to treat solid tumors.
Penn Founder: Malay Haldar, PhD (Penn Medicine)
PCI Ventures (UPstart)
Triso Therapeutics
Triso Therapeutics
Small molecules for targeted intervention of hematologic malignancies.
Penn Founder: Erle Robertson, PhD (Penn Medicine)
PCI Ventures (UPstart)
Peroxitech
Peroxitech
Novel therapeutic to prevent acute lung injury, the major cause of death with sepsis.
Penn Founders: Aron Fisher, MD & Sheldon Feinstein, PhD (Penn Medicine)
PCI Ventures (UPstart)
Recent News
All PCI Ventures PostsUpcoming Events
All EventsThe Team

Michael D. Poisel, MS, MBA
Executive Director, PCI Ventures

Bhavana Mohanraj, PhD
Interim Executive Director, PCI Ventures

Yi-Yen Chen, PhD
Associate Director, PCI Ventures

Melisa Lopez-Anton, PhD
Assistant Director, PCI Ventures

Raquel Giron
Administrative Coordinator
Our Partners









